A study out of Ontario, Canada found an immediate cancer diagnosis decrease of 34% in March 2020, followed by a slow and incomplete recovery.
FDA has approved for FoundationOne CDx to be used as a companion diagnostic to identify patients with non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) alterations and are appropriate for treatment with EGFR tyrosine kinase inhibitors approved by FDA for this indication.
Strata Oncology Inc. announced enrollment of the first patient in the Strata Sentinel trial, a prospective, observational study that will evaluate the ability of the investigational StrataMRD test to detect cancer recurrence in advance of standard of care techniques across solid tumors, as well as the clinical benefit of treatment in early-stage patients who are or become ctDNA-positive after surgery or other therapy with curative intent.
Congress has passed an omnibus spending bill containing 12 FY22 appropriations bills and additional funding for Ukraine.
The Mark Foundation for Cancer Research selected four scientific research projects to receive $12 million in funding for its 2022 Endeavor Awards.
Ronald Caplan, founder and president of PMC Property Group, Inc., and his wife Ellen have donated $10 million to the NCI-designated Wistar Cancer Center in Philadelphia, now renamed the Ellen and Ronald Caplan Cancer Center of The Wistar Institute.
The American Cancer Society awarded the University of Illinois Cancer Center a $4.08 million, four-year grant to establish the Illinois Cancer Health Equity Research Center (I-CHER C), a consortium of health care researchers and clinicians charged with improving outcomes in communities disproportionately affected by cancer.
The Prevent Cancer Foundation announced funding for seven scientists who are researching cancer prevention and early detection. Each scientist has been awarded $100,000 for two years.
Debbie Weir was named chief executive officer of the Cancer Support Community.
Thermo Fisher Scientific is calling for proposals for its Oncomine Clinical Research Grant. The latest request for submissions will award funding for molecular profiling research that helps accelerate the use of genomic sequencing in oncology.
